HomeChina

China

BoxPlus Information Technology Company Receives Investment From IQAX

BoxPlus Information Technology Company, a Shanghai, China-based provider of Internet of Things (IoT) solutions, received an investment from IQAX. The amount of the deal was...

Trax Receives $50M Financing

Trax, a Boston, MA-based provider of image recognition solutions for brick-and-mortar retail, raised $50M in financing. Deutsche Bank Private Credit & Infrastructure provided the financing. The...

OrbiMed Raises $4.3 Billion Across Three Private Investment Funds

OrbiMed, a global healthcare investment firm, raised more than $4.3 billion in commitments for its latest private investment funds. Investors in these new funds include a...

Triastek Closes USD 20.4M Pre-C Funding Round

Triastek, a Nanjing, China-based company which specializes in 3D printing for pharmaceutical industry, raised USD 20.4M in Pre-C funding. The round was led by Guoxin...

SuperOrdinary Closes $58M Series B Funding

SuperOrdinary, a Shanghai, New York City, and Los Angeles-based global brand accelerator and expert in establishing and scaling brands in international and domestic channels,...

Prins AI Raises $100M in Series B Funding

Prins AI, a technology company utilizing advanced AI to create digital identities for enterprises, brands, celebrities, and individuals, closed a $100m Series B financing...

Hydrexia Closes Series D Private Equity Financing

Hydrexia Holding Limited, a Shanghai, China-based integrated hydrogen technology solution provider, completed its Series D of private equity financing. The amount of the deal was...

Lynk Pharmaceuticals Completes Series C2 Financing

Lynk Pharmaceuticals, a Hangzhou, China-based clinical stage company, raised an undisclosed amount in Series C2 funding. The round saw participation from Shaoxing Binhai New Area...

Canton Biologics Completes Over 300M Yuan Series C Financing

Canton Biologics, a Guangzhou, China-based molecule biopharmaceutical CDMO, raised over 300M Yuan in Series C funding. The round was led by SDIC Venture Capital, with...

BlueRun Ventures China Rebrands to Lanchi Ventures

BlueRun Ventures China, a Beijing, China-based early-stage technology-focused venture firm, is changing its English brand to Lanchi Ventures. The firm has launched a new...

Grit Biotechnology Closes $60M Series B Financing

Grit Biotechnology, a Shanghai, China-based cell therapy company, raised $60M in Series B funding. The round was led by CICC with participation from Qianhai Ark,...

Innovac Therapeutics Closes $18M Series Pre-A Financing

Innovac Therapeutics, a Boston, MA-, Shanghai and Hangzhou, China-based mRNA therapeutics company, raised $18M in Series Pre-A funding. The round saw participation from Elikon Venture,...

THE DAILY NEWSLETTER - SIGNUP